WO2008030803A3 - Hiv inhibitors - Google Patents
Hiv inhibitors Download PDFInfo
- Publication number
- WO2008030803A3 WO2008030803A3 PCT/US2007/077527 US2007077527W WO2008030803A3 WO 2008030803 A3 WO2008030803 A3 WO 2008030803A3 US 2007077527 W US2007077527 W US 2007077527W WO 2008030803 A3 WO2008030803 A3 WO 2008030803A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- small molecule
- molecule inhibitors
- inhibitors
- hiv fusion
- fusion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
Abstract
The present invention provides a system for identifying HIV fusion inhibitors, and particularly for identifying small molecule inhibitors compounds that inhibit HIV fusion. The present invention further provides small molecule inhibitors of HIV fusion. In some embodiments, the invention provides small molecule inhibitors that bind to gp41. In some embodiments, inventive small molecule inhibitors block the gp41 conformational change associated with fusion. In some embodiments, inventive small molecule inhibitors inhibit binding of a peptide that corresponds to a portion of the gp41 outer layer with its site on the gp41 inner core.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84221906P | 2006-09-03 | 2006-09-03 | |
US60/842,219 | 2006-09-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008030803A2 WO2008030803A2 (en) | 2008-03-13 |
WO2008030803A3 true WO2008030803A3 (en) | 2008-11-06 |
Family
ID=39157975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/077527 WO2008030803A2 (en) | 2006-09-03 | 2007-09-04 | Hiv inhibitors |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008030803A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8455516B2 (en) | 2010-01-15 | 2013-06-04 | Touro University | HIV-1 fusion inhibitors and methods |
-
2007
- 2007-09-04 WO PCT/US2007/077527 patent/WO2008030803A2/en active Application Filing
Non-Patent Citations (2)
Title |
---|
LIU S. ET AL.: "Identification of Inhibitors of the HIV-1 gp41 Six-helix bundle Formation from Extracts of Chinese Medicanal Herbs Prunella Vulgaris and Rhizoma cibotte", LIFE SCIENCES, vol. 71, 2002, pages 1779 - 1791 * |
ZHAO ET AL.: "XTT Formazan Widely used to Detect Cell Viability Inhibits HIV Type 1 Infection in Vitro by Targeting gp41", AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 18, no. 14, 2002 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008030803A2 (en) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009070243A3 (en) | Wise binding antibodies and epitopes | |
WO2007093627A3 (en) | Biocidal composition | |
WO2009058383A3 (en) | Ligand | |
WO2008066642A3 (en) | Transdermal delivery systems comprising bupivacaine | |
EP1913518A4 (en) | System for transacting with a trading application | |
EP2013298A4 (en) | Compositions for forming reflecting layer having organic silver complexes,and method for preparing reflecting layer using same | |
EP1991497B8 (en) | Method for depositing high aspect ratio molecular structures | |
WO2007148300A3 (en) | Methods and systems for push-to-storage | |
EP1846185A4 (en) | Composite track, column and other supports, including for machinery | |
WO2008038127A8 (en) | Junctional adhesion molecule-c (jam-c) binding compounds and methods of their use | |
DE602007006610D1 (en) | Insulation-penetrating and SMD-capable contact element, and method for its use. | |
WO2007143086A3 (en) | Delivery method | |
WO2009024726A3 (en) | Method for purifying or detecting a target protein | |
DK1704485T3 (en) | APPROVAL PROCEDURE | |
WO2007090002A3 (en) | Alignment correction system and methods of use thereof | |
WO2007056083A3 (en) | Biosynthetic polypeptide fusion inhibitors | |
WO2007077553A3 (en) | Solid fuel | |
WO2008051539A3 (en) | Processes for preparing palonosetron salts | |
WO2008008155A3 (en) | Small molecule modulators of p53 family signaling | |
NO20065472L (en) | Re-gasification of LNG. | |
WO2009131943A3 (en) | System and method for managing trading orders with decaying reserves | |
WO2008113916A9 (en) | Pharmaceutical composition containing antibodies directed against the herv-w envelope | |
WO2008014084A3 (en) | Pipeline | |
WO2008070602A3 (en) | Topical pharmaceutical composition | |
WO2008030803A3 (en) | Hiv inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07841820 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07841820 Country of ref document: EP Kind code of ref document: A2 |